Antiprotozoal activity of ferroquine

Pomel, S.; Biot, Christophe; Bories, C; Loiseau, P.M.

Type de document :

Article dans une revue scientifique

DOI :

10.1007/s00436-012-3183-4

PMID :

23229318

URL permanente :

http://hdl.handle.net/20.500.12210/18222

Titre :

Antiprotozoal activity of ferroquine

Auteur(s) :

Pomel, S. [Auteur]
Biomolécules : Conception, Isolement, Synthèse [BioCIS]
Biot, Christophe [Auteur]

Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Unité de Glycobiologie Structurale et Fonctionnelle - UMR 8576 [UGSF]
Bories, C [Auteur]
Biomolécules : Conception, Isolement, Synthèse [BioCIS]
Loiseau, P.M. [Auteur]
Biomolécules : Conception, Isolement, Synthèse [BioCIS]

Titre de la revue :

Parasitology research

Nom court de la revue :

Parasitol. Res.

Numéro :

112

Pagination :

665-669

Date de publication :

2013-02

ISSN :

1432-1955

Discipline(s) HAL :

Chimie/Chimie théorique et/ou physique

Résumé en anglais : [en]

Ferroquine (FQ, SSR97193) is a synthetic compound currently in development for the treatment of malaria. The use of a single compound to treat several parasitoses would be very convenient for multi-infected patients and ...
Lire la suite >Ferroquine (FQ, SSR97193) is a synthetic compound currently in development for the treatment of malaria. The use of a single compound to treat several parasitoses would be very convenient for multi-infected patients and also for financial considerations. In this work, the activity of FQ was investigated on three other Protista parasites: Kinetoplastidae (Leishmania and Trypanosoma) and the cosmopolite parasite Trichomonas vaginalis. FQ exhibited a significant in vitro activity on Trypanosoma brucei brucei and Trypanosoma brucei gambiense, the agents of African trypanosomiasis in a range from 0.2 to 3.1 μM. In vivo, intraperitoneally administered FQ demonstrated a weak but significant trypanocidal activity at 100 μmol/kg, which is however higher than the maximum tolerated dose. The drop of the parasitemia of the treated mice was significantly related to the amount of injected FQ. Furthermore, this organometallic compound was responsible for a delay in the appearance of bloodstream parasites at 50 μmol/kg. However, it was not able to cure infected mice. Although no synergy was identified in vitro between FQ and pentamidine, these results justify further investigations by evaluating analogues in this chemical series.Lire moins >

Langue :

Anglais

Audience :

Non spécifiée

Établissement(s) :

CNRS
Université de Lille

Collections :

Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576

Équipe(s) de recherche :

Chemical Glycobiology

Date de dépôt :

2020-02-12T15:11:06Z
2021-05-07T06:50:37Z

Numéro de version	Lien	Date de modification
2	20.500.12210/18222*	2021-05-07T06:46:41Z
1	20.500.12210/18222.1	2020-02-12T15:11:06Z

Antiprotozoal activity of ferroquine

BibTeX

CSV

Excel

RIS

Historique des modifications

Antiprotozoal activity of ferroquine BibTeX CSV Excel RIS

Historique des modifications

Antiprotozoal activity of ferroquine

BibTeX

CSV

Excel

RIS